Search Results - "Lotesoriere, Claudio"
-
1
Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell lines
Published in Scientific reports (28-04-2020)“…Ramucirumab is approved both as monotherapy and in combination with Paclitaxel for advanced gastric cancer in patients with disease progression after…”
Get full text
Journal Article -
2
Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications
Published in International journal of molecular sciences (15-07-2024)“…Autotaxin (ATX) is a member of the ectonucleotide pyrophosphate/phosphodiesterase ( ) family; it is encoded by the gene. ATX is a secreted glycoprotein and…”
Get full text
Journal Article -
3
Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab-paclitaxel therapy outcome in advanced gastric cancer: results of prospective study
Published in Frontiers in oncology (14-04-2023)“…[This corrects the article DOI: 10.3389/fonc.2022.862116.]…”
Get full text
Journal Article -
4
Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab-Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study
Published in Frontiers in oncology (06-04-2022)“…The combination of paclitaxel and ramucirumab is the second-line therapy of choice in the treatment of advanced gastric cancer. To date, no biomarkers are…”
Get full text
Journal Article -
5
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
Published in Frontiers in oncology (16-02-2023)“…Paclitaxel (PTX) interferes with microtubule architecture by binding to β-tubulin, thereby blocking progression at the G2/M phase and inducing apoptosis. This…”
Get full text
Journal Article -
6
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer
Published in Journal of oncology (01-01-2019)“…Extracellular vesicles (EVs) are involved in intercellular communication during the carcinogenesis. Our attention has been focused on small EVs (sEVs) protein…”
Get full text
Journal Article -
7
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment
Published in Biomedicines (07-10-2023)“…Metastatic gastric cancer (mGC) often has a poor prognosis and may benefit from a few targeted therapies. Ramucirumab-based anti-angiogenic therapy targeting…”
Get full text
Journal Article -
8
Characterization of a rare variant (c.2635-2A>G) of the MSH2 gene in a family with Lynch syndrome
Published in The International journal of biological markers (01-11-2018)“…Introduction: Lynch syndrome is caused by germline mutations in one of the mismatch repair genes (MLH1, MSH2, MSH6, and PMS2) or in the EPCAM gene. Lynch…”
Get full text
Journal Article -
9
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis
Published in Expert opinion on biological therapy (01-02-2015)“…To assess the predictive role of lactate dehydrogenases (LDH) and fibrinogen (FBG) serum levels in metastatic colorectal cancer (mCRC) patients receiving a…”
Get more information
Journal Article -
10
Hepatitis C Virus Infection Involves CD34+Hematopoietic Progenitor Cells in Hepatitis C Virus Chronic Carriers
Published in Blood (01-11-1998)“…Although hepatitis C virus (HCV) mainly affects hepatocytes, infection is widespread and involves immunologically privileged sites. Whether lymphoid cells…”
Get full text
Journal Article -
11
Integrated immune gene expression signature and molecular classification in gastric cancer: New insights
Published in Journal of leukocyte biology (01-08-2020)“…Gastric cancer (GC) is characterized by extreme heterogeneity due to histopathological differences, molecular characteristics, and immune gene expression…”
Get full text
Journal Article -
12
Immunotherapy in biliary tract cancer: are we finally on the right path?
Published in The lancet. Gastroenterology & hepatology (01-08-2024)Get more information
Journal Article -
13
High levels of autotaxin and lysophosphatidic acid predict poor outcome in treatment of resectable gastric carcinoma
Published in European journal of cancer (1990) (01-12-2024)“…Although early-stage gastric cancer is a candidate for curative surgical resection, the absence of specific early symptoms results in a late diagnosis and…”
Get full text
Journal Article -
14
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Published in Cancers (20-10-2024)“…Treatment options for intrahepatic cholangiocarcinoma (iCCA), a highly malignant tumor with poor prognosis, are limited. Recent developments in immunotherapy…”
Get full text
Journal Article -
15
Durvalumab in advanced cholangiocarcinoma: is someone knocking down the door?
Published in Immunotherapy (01-05-2023)“…Following the practice-changing results observed in several hematological and solid tumors, immunotherapy with immune checkpoint inhibitors (ICIs) has been…”
Get full text
Journal Article -
16
Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
Published in Medicine (Baltimore) (01-06-2017)“…Pancreatic neuroendocrine tumors (PNETs) account for less than 5% of all pancreatic tumors. PNETs develop from pancreatic endocrine islet cells and have a…”
Get full text
Journal Article -
17
Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues
Published in Cancers (19-04-2023)“…Although biliary tract cancers are traditionally considered rare in Western countries, their incidence and mortality rates are rising worldwide. A better…”
Get full text
Journal Article -
18
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)
Published in Tumori (01-06-2024)“…Introduction: About 90% of cholangiocarcinomas are adenocarcinomas with glandular or tubular structures lined by epithelial cells, with no bile production and…”
Get full text
Journal Article -
19
Identification and Somatic Characterization of the Germline PTEN Promoter Variant rs34149102 in a Family with Gastrointestinal and Breast Tumors
Published in Genes (05-04-2022)“…Genetic variants located in non-coding regions can affect processes that regulate protein expression, functionally contributing to human disease. Germline…”
Get full text
Journal Article -
20
Abstract 3700: Genomic alterations on first-line panitumumab plus FOLFIRI in metastatic colorectal cancer
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Background: IMPROVE is a randomized, non-comparative multicenter, phase 2 study evaluating continuous or intermittent FOLFIRI/PANI, in first-line in…”
Get full text
Journal Article